| Dr Clark Dennis Wymore, DDS | |
|
121 S Dodge St, Algona, IA 50511-2639 | |
| (515) 295-5331 | |
| Not Available |
| Full Name | Dr Clark Dennis Wymore |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 121 S Dodge St, Algona, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063635357 | NPI | - | NPPES |
| 0082941 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 5980 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clark Dennis Wymore, DDS 121 S Dodge St, Algona, IA 50511-2639 Ph: (515) 295-5331 | Dr Clark Dennis Wymore, DDS 121 S Dodge St, Algona, IA 50511-2639 Ph: (515) 295-5331 |
News Archive
Test-tube fertilisation is the reason why more couples than previously now have the chance to become biological parents. However, the path to achieving this can be laborious and, for some, the treatment is unsuccessful. A thesis from the University of Gothenburg, Sweden, indicates that people are more negatively affected than previously reported in studies of involuntary childlessness.
Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.
Eviagenics, a French biotech company, is pleased to announce the closing of a series A financing round to scale up its technical and commercial development. At this occasion the FCPR Emertec 4 managed by Emertec Management, CEA Investissement, and Genopole Premier Jour managed by CapDecisif Management provide a total contribution of EUR 1.3 million.
Ischemic stroke patients who arrive at the hospital too late to receive currently available treatment options might someday have a new treatment option. Northwestern Memorial Hospital is the only site in Chicago to participate in a phase III trial of abciximab (ReoPro - Centocor/Eli Lilly and Company), which seeks to determine the drug's ability to improve neurological function and minimize disability in patients who present with an acute ischemic stroke.
› Verified 5 days ago
Mark Allen Jensen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 208 East Call Street, Algona, IA 50511 Phone: 515-295-2303 Fax: 515-295-2011 | |
Dr. William Edward Strohman, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 E Call St, Algona, IA 50511 Phone: 515-295-5200 Fax: 515-295-4911 | |
Dr. Monte F Grandgeorge, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 310 E Call St, Algona, IA 50511 Phone: 515-295-2334 Fax: 515-395-2334 | |
Dr. Aaron M Louscher, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 310 E Call St, Algona, IA 50511 Phone: 515-295-2334 Fax: 515-395-2334 | |
Anthony Julius Brantner, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 310 E Call St, Algona, IA 50511 Phone: 515-295-2334 Fax: 515-395-2334 | |
Matthew Paul Merideth, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 310 E Call St, Algona, IA 50511 Phone: 515-295-2334 Fax: 515-395-2334 |